NCT04884308View on ClinicalTrials.gov

Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 28, 2021

Primary Completion Date

December 30, 2023

Study Completion Date

December 30, 2023

Conditions
Cystic FibrosisBronchiectasis AdultNon-Tuberculous Mycobacteria
Interventions
BIOLOGICAL

BCG TICE Vaccine

Intradermal vaccination with BCG TICE

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Johns Hopkins University

OTHER